Cell MedX Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cell MedX Corp. generated cash of -$145,898, which is more than the previous year. Cash used in financing activities reached the amount of $91,033 last year. Net change in cash is therefore -$54,880.
Cash Flow
| 2015 | -316.81K | -27.80K | 345.24K |
|---|---|---|---|
| 2016 | -421.57K | -218.79K | 666.78K |
| 2017 | -754.05K | -110.23K | 904.22K |
| 2018 | -449.42K | 0 | 388.13K |
| 2019 | -307.54K | -1.91K | 359.12K |
| 2020 | -925.84K | -2.46K | 916.42K |
| 2021 | -560.43K | -1.57K | 535.09K |
| 2022 | -450.59K | 0 | 453.97K |
| 2023 | -272.20K | 0 | 346.36K |
| 2024 | -145.89K | 0 | 91.03K |
CMXC Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 98.29K | 24.38K | 20.75K | 45.09K | 57.17K | 8.2K | 67.49K | 27.56K | 1.25K | 1.20K |
Operating activities | ||||||||||
Net income | -142.48K | -495.04K | -697.37K | -910.83K | -1.09M | -905.98K | -1.54M | -1.24M | -2.13M | -1.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 1.14K | 2.43K | 1.84K | 580 | 0 | 123.04K | 20.60K | 1.95K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117.48K | 868.16K | 203.82K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117.48K | 868.16K | 203.82K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 8.82K | 0 | 50.81K | 99.32K | 0 | 0 |
Inventories | 0 | 0 | 0 | 12.71K | 20.50K | -64.31K | -6.01K | -4.31K | -3.92K | -729 |
Accounts payable | 46.75K | -14.06K | 19.95K | 54.08K | 46.57K | 141.58K | 146.31K | 85.30K | 136.27K | 222.79K |
Cash generated by operating activities | -145.89K | -272.20K | -450.59K | -560.43K | -925.84K | -307.54K | -449.42K | -754.05K | -421.57K | -316.81K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1 | 0 | 0 | -1.57K | -2.46K | -1.91K | 0 | -110.23K | -218.79K | -27.80K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | -1.57K | -2.46K | -1.91K | 0 | -110.23K | -218.79K | -27.80K |
Financing activities | ||||||||||
Common Stock Issued | 75K | 0 | 160K | 207K | 486K | 0 | 0 | 357.5K | 0 | 75K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 16.03K | 346.36K | 293.97K | -328.09K | -327.65K | 297.00K | 0 | 512.82K | 0 | 205K |
Cash used in financing activities | 91.03K | 346.36K | 453.97K | 535.09K | 916.42K | 359.12K | 388.13K | 904.22K | 666.78K | 345.24K |
Net Change In Cash | -54.88K | 73.91K | 3.62K | -24.33K | -12.08K | 48.97K | -59.29K | 39.93K | 26.30K | 57 |
Cash at end of period | 43.41K | 98.29K | 24.38K | 20.75K | 45.09K | 57.17K | 8.2K | 67.49K | 27.56K | 1.25K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |